• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Incidence and clinical characteristics of gastroenteropancreatic neuroendocrine tumor in Korea: a single-center experience.韩国胃肠胰神经内分泌肿瘤的发病率及临床特征:单中心经验
Korean J Intern Med. 2017 May;32(3):452-458. doi: 10.3904/kjim.2015.232. Epub 2016 Mar 29.
2
Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors.一种新型TNM分类系统对上消化道胰腺神经内分泌肿瘤的预后相关性
Cancer. 2008 Jul 15;113(2):256-65. doi: 10.1002/cncr.23549.
3
Evaluation of the concordance between the stage of the disease and Ki-67 proliferation index in gastroenteropancreatic neuroendocrine tumors.胃肠胰神经内分泌肿瘤中疾病分期与Ki-67增殖指数之间的一致性评估。
Eur J Gastroenterol Hepatol. 2016 Jul;28(7):836-41. doi: 10.1097/MEG.0000000000000619.
4
Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors.胃肠胰神经内分泌肿瘤的部位特异性生物学与病理学
Virchows Arch. 2007 Aug;451 Suppl 1:S9-27. doi: 10.1007/s00428-007-0461-0. Epub 2007 Aug 8.
5
Best prognostic factor of neuroendocrine tumors: Grade or Stage? A multidisciplinary single-center study.神经内分泌肿瘤的最佳预后因素:分级还是分期?一项多学科单中心研究。
Turk J Gastroenterol. 2016 Nov;27(6):509-514. doi: 10.5152/tjg.2016.16391.
6
Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters.胃肠胰神经内分泌肿瘤:基于世界卫生组织和欧洲神经内分泌肿瘤学会分类的当前发病率和分期:基于前瞻性收集参数的分析。
Endocr Relat Cancer. 2010 Oct 5;17(4):909-18. doi: 10.1677/ERC-10-0152. Print 2010 Dec.
7
Gastroenteropancreatic Neuroendocrine Tumors with Liver Metastases in Korea: A Clinicopathological Analysis of 72 Cases in a Single Institute.韩国伴有肝转移的胃肠胰神经内分泌肿瘤:单机构72例临床病理分析
Cancer Res Treat. 2015 Oct;47(4):738-46. doi: 10.4143/crt.2014.224. Epub 2015 Feb 16.
8
Gastroenteropancreatic (neuro)endocrine neoplasms: the histology report.胃肠胰(神经)内分泌肿瘤:组织学报告。
Dig Liver Dis. 2011 Mar;43 Suppl 4:S356-60. doi: 10.1016/S1590-8658(11)60591-4.
9
Gastroenteropancreatic neuroendocrine tumours: Clinicopathological evaluation at Shifa International Hospital, Islamabad.胃肠胰神经内分泌肿瘤:伊斯兰堡 Shifa 国际医院的临床病理评估。
J Pak Med Assoc. 2021 Feb;71(2(A)):492-496. doi: 10.47391/JPMA.835.
10
Clinicopathological Features of Neuroendocrine Tumors in Gastroenteropancreatic Tract: A Single Center Study.胃肠道胰腺神经内分泌肿瘤的临床病理特征:一项单中心研究
Cureus. 2022 Jul 28;14(7):e27384. doi: 10.7759/cureus.27384. eCollection 2022 Jul.

引用本文的文献

1
Current advances in neuroendocrine neoplasms of the colon and rectum.结肠和直肠神经内分泌肿瘤的当前进展
World J Clin Oncol. 2025 Aug 24;16(8):108906. doi: 10.5306/wjco.v16.i8.108906.
2
Epidemiological insights and survival patterns in neuroendocrine neoplasia: a geographic perspective.神经内分泌肿瘤的流行病学见解与生存模式:地域视角
Endocr Oncol. 2025 Aug 5;5(1):e250039. doi: 10.1530/EO-25-0039. eCollection 2025 Jan.
3
Endoscopic Treatment of Gastric Neuroendocrine Tumors: What's Next?胃神经内分泌肿瘤的内镜治疗:下一步何去何从?
Gut Liver. 2025 Mar 15;19(2):148-150. doi: 10.5009/gnl250107.
4
Clinicopathologic characteristics of neuroendocrine tumors with assessment by digital image analysis for Ki-67 index with a focus on the gastroenteropancreatic tract: a single-center study.通过数字图像分析评估Ki-67指数的神经内分泌肿瘤的临床病理特征,重点关注胃肠胰道:一项单中心研究
Int J Clin Exp Pathol. 2023 Sep 15;16(9):225-234. eCollection 2023.
5
Clinicopathological Findings and Treatment Outcomes of Patients with Primary Hepatobiliary Neuroendocrine Neoplasms: A Retrospective Single-institution Analysis.原发性肝胆神经内分泌肿瘤患者的临床病理特征和治疗结果:回顾性单中心分析。
Intern Med. 2024 Apr 1;63(7):891-901. doi: 10.2169/internalmedicine.2016-23. Epub 2023 Aug 23.
6
Classification and Locoregional Treatment of Rectal Neuroendocrine Tumors.直肠神经内分泌肿瘤的分类与局部区域治疗
Cureus. 2023 Jun 8;15(6):e40128. doi: 10.7759/cureus.40128. eCollection 2023 Jun.
7
Endoscopic treatment for rectal neuroendocrine tumor: which method is better?直肠神经内分泌肿瘤的内镜治疗:哪种方法更好?
Clin Endosc. 2022 Jul;55(4):496-506. doi: 10.5946/ce.2022.115. Epub 2022 Jul 11.
8
Neuroendocrine Tumors: a Relevant Clinical Update.神经内分泌肿瘤:相关临床进展
Curr Oncol Rep. 2022 Jun;24(6):703-714. doi: 10.1007/s11912-022-01217-z. Epub 2022 Mar 7.
9
Rectal Neuroendocrine Neoplasms: Why Is There a Global Variation?直肠神经内分泌肿瘤:为什么存在全球差异?
Curr Oncol Rep. 2022 Mar;24(3):257-263. doi: 10.1007/s11912-021-01172-1. Epub 2022 Jan 27.
10
Epidemiology, Incidence, and Prevalence of Neuroendocrine Neoplasms: Are There Global Differences?神经内分泌肿瘤的流行病学、发病率和患病率:是否存在全球差异?
Curr Oncol Rep. 2021 Mar 14;23(4):43. doi: 10.1007/s11912-021-01029-7.

本文引用的文献

1
Current Trends of the Incidence and Pathological Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) in Korea 2000-2009: Multicenter Study.2000-2009 年韩国胃肠胰神经内分泌肿瘤(GEP-NETs)发病和病理诊断的趋势:多中心研究。
Cancer Res Treat. 2012 Sep;44(3):157-65. doi: 10.4143/crt.2012.44.3.157. Epub 2012 Sep 30.
2
Gastroenteropancreatic neuroendocrine tumors: incidence and treatment outcome in a single institution in Korea.胃肠胰神经内分泌肿瘤:韩国一家机构的发病率及治疗结果
Asia Pac J Clin Oncol. 2011 Sep;7(3):293-9. doi: 10.1111/j.1743-7563.2011.01423.x.
3
Clinical characteristics of colorectal carcinoid tumors.结直肠癌类癌肿瘤的临床特征。
J Korean Soc Coloproctol. 2011 Feb;27(1):17-20. doi: 10.3393/jksc.2011.27.1.17. Epub 2011 Feb 28.
4
Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients.胰腺内分泌肿瘤:改良的 TNM 分期和组织病理学分级可对患者进行临床有效的预后分层。
Mod Pathol. 2010 Jun;23(6):824-33. doi: 10.1038/modpathol.2010.58. Epub 2010 Mar 19.
5
Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan.日本胃肠胰神经内分泌肿瘤的流行病学研究。
J Gastroenterol. 2010 Feb;45(2):234-43. doi: 10.1007/s00535-009-0194-8.
6
Neuroendocrine gastroenteropancreatic tumors: ESMO clinical recommendation for diagnosis, treatment and follow-up.神经内分泌胃肠胰腺肿瘤:ESMO关于诊断、治疗及随访的临床建议
Ann Oncol. 2009 May;20 Suppl 4:150-3. doi: 10.1093/annonc/mdp158.
7
Prognostic factors and survival in 324 patients with pancreatic endocrine tumor treated at a single institution.单机构治疗的324例胰腺内分泌肿瘤患者的预后因素及生存情况
Clin Cancer Res. 2008 Dec 1;14(23):7798-803. doi: 10.1158/1078-0432.CCR-08-0734.
8
Neuroendocrine tumor epidemiology: contrasting Norway and North America.神经内分泌肿瘤流行病学:挪威与北美的对比
Cancer. 2008 Nov 15;113(10):2655-64. doi: 10.1002/cncr.23883.
9
Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours.胃肠胰神经内分泌肿瘤长期预后的预测因素
Endocr Relat Cancer. 2008 Dec;15(4):1083-97. doi: 10.1677/ERC-08-0017. Epub 2008 Jul 4.
10
One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.“类癌”百年之后:美国35825例神经内分泌肿瘤的流行病学及预后因素
J Clin Oncol. 2008 Jun 20;26(18):3063-72. doi: 10.1200/JCO.2007.15.4377.

韩国胃肠胰神经内分泌肿瘤的发病率及临床特征:单中心经验

Incidence and clinical characteristics of gastroenteropancreatic neuroendocrine tumor in Korea: a single-center experience.

作者信息

Lim Chul-Hyun, Lee In Seok, Jun Byoung Yeon, Kim Jin Su, Cho Yu Kyung, Park Jae Myung, Roh Sang Young, Lee Myung Ah, Kim Sang Woo, Choi Myung-Gyu

机构信息

Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.

出版信息

Korean J Intern Med. 2017 May;32(3):452-458. doi: 10.3904/kjim.2015.232. Epub 2016 Mar 29.

DOI:10.3904/kjim.2015.232
PMID:28490723
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5432789/
Abstract

BACKGROUND/AIMS: Neuroendocrine tumors (NETs) may originate from heterogeneous neuroendocrine cells. The incidence is increasing worldwide, and World Health Organization (WHO) updated its classification in 2010. We investigated clinical characteristics of gastroenteropancreatic NETs in a single center.

METHODS

Clinicopathologic characteristics of patients with pathologically confirmed gastroenteropancreatic NET in Seoul St. Mary Hospital from March 2009 to August 2011 were retrospectively analyzed. The grade and stage were determined according to WHO 2010 classification and TNM Staging System for Neuroendocrine Tumors (7th ed., 2010) of American Joint Committee on Cancer.

RESULTS

One hundred and twenty-five patients (median age, 50; male, 61.3%) were analyzed. Among 100,000 patients who visited the hospital, incidence was 24.1. Only two patients (1.6%) had a functional NET. The rectum (n = 99, 79.8%) was most common primary site and found in early stage. The prevalence by stages was 84.7% stage I, 8.9% stage IV, 4.8% stage II, and 1.6% stage III. The pathology grading was 74.5% grade 1, 12.7% grade 2, and 12.7% grade 3. Tumor stage correlated positively with pathologic grade (Spearman's rank correlation coefficient, 0.644).

CONCLUSIONS

Wide range of clinicopathological features of Korean gastroenteropancreatic NETs were demonstrated using WHO 2010 classification. Rectal NET was most frequent and found in early stage.

摘要

背景/目的:神经内分泌肿瘤(NETs)可能起源于异质性神经内分泌细胞。其发病率在全球范围内呈上升趋势,世界卫生组织(WHO)于2010年更新了其分类。我们在单一中心调查了胃肠胰神经内分泌肿瘤的临床特征。

方法

回顾性分析2009年3月至2011年8月在首尔圣母医院经病理确诊的胃肠胰神经内分泌肿瘤患者的临床病理特征。根据WHO 2010分类和美国癌症联合委员会的神经内分泌肿瘤TNM分期系统(第7版,2010年)确定分级和分期。

结果

分析了125例患者(中位年龄50岁;男性占61.3%)。在100000例就诊患者中,发病率为24.1。仅有2例患者(1.6%)患有功能性神经内分泌肿瘤。直肠(n = 99,79.8%)是最常见的原发部位,且多在早期发现。各分期的患病率分别为:I期84.7%,IV期8.9%,II期4.8%,III期1.6%。病理分级为1级占74.5%,2级占12.7%,3级占12.7%。肿瘤分期与病理分级呈正相关(Spearman等级相关系数为0.644)。

结论

采用WHO 2010分类展示了韩国胃肠胰神经内分泌肿瘤广泛的临床病理特征。直肠神经内分泌肿瘤最为常见且多在早期发现。